research use only

Adefovir Dipivoxil (GS 0840) Reverse Transcriptase inhibitor

Cat.No.S1718

Adefovir Dipivoxil (GS 0840) is a reverse transcriptase inhibitor used in the treatment of chronic hepatitis B virus (HBV).
Jump to

Quality Control

Batch: Purity: 99.99%
99.99

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (199.41 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 501.47 Formula

C20H32N5O8P

Storage (From the date of receipt)
CAS No. 142340-99-6 Download SDF Storage of Stock Solutions

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
HBV RT
In vivo
Adefovir Dipivoxil (GS 0840) reduces Liver HBV DNA to <0.1 pg of viral DNA per mg of total DNA (pg/mg) in transgenic mice expressing hepatitis B virus. This compound also reduces serum HBV DNA to 3.5 log10 genomic equivalents (ge)/mL in the same model, compared to 5.3 log10 ge/mL for the placebo control group. Its antiviral activity reaches near maximum viral reduction by day 10 in the liver and achieves an endpoint of liver virus inhibition at 1.0 mg/kg/day.
References
  • [4] https://pubmed.ncbi.nlm.nih.gov/10718947/
  • [5] https://pubmed.ncbi.nlm.nih.gov/12865451/

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2021-03-29)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT00973219 COMPLETED
Chronic Hepatitis B
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
2009-09
NCT02965859 UNKNOWN
Chronic Hepatitis B
Guangzhou Yipinhong Pharmaceutical CO.,LTD
2012-12 PHASE2
NCT02327416 UNKNOWN
Hepatitis B, Chronic
Tongji Hospital
2014-10 PHASE3
NCT00810524 UNKNOWN
Hepatitis B, Chronic
Sun Yat-sen University
2007-01 PHASE4
NCT02826070 UNKNOWN
Hepatitis B, Chronic
Nanfang Hospital, Southern Medical University
2015-04 PHASE4
NCT02327689 UNKNOWN
Hepatitis B, Chronic; Fibrosis
Asian-Pacific Alliance of Liver Disease, Beijing
2015-01 PHASE4

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map